Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Mesothelioma, Malignant × Midazolam × Clear all

Sponsor

Conditions

Neoplasms 3 Melanoma 2 Lung Neoplasms 2 Colonic Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Breast Neoplasms 2 Urothelial Cancer 1 Synovitis, Pigmented Villonodular 1 Solid Tumor 1 Skin Neoplasms 1 Rectal Neoplasms 1 Polyps 1 Patient Satisfaction 1 Neoplasm Metastasis 1 Lymphoma, Non-Hodgkin 1 Leukemia, Myeloid, Acute 1 Glioma 1 Diverticulosis, Colonic 1 Central Nervous System Neoplasms 1 Carcinoma, Squamous Cell 1 Carcinoma, Basal Cell 1 Carcinoma 1 Brain Neoplasms 1 Brain Diseases 1 Anxiety Disorders 1 Advanced Cancer 1

Interventions

Pemetrexed 14 Cisplatin 13 pembrolizumab 4 Platinum 4 1,2-diaminocyclohexaneplatinum II citrate 4 Radiotherapy 3 Gemcitabine 3 Carboplatin 3 cediranib 2 amatuximab 2 Radiotherapy, Intensity-Modulated 2 Radiation 2 Drug Therapy 2 Cyclophosphamide 2 tumor necrosis factor-alpha, CNGRC fusion protein, human 1 tremelimumab 1 sodium thiosulfate 1 sargramostim 1 nintedanib 1 napabucasin 1 methoxyamine 1 liposomal doxorubicin 1 incomplete Freund's adjuvant 1 fresolimumab 1 durvalumab 1 defactinib 1 cixutumumab 1 bintrafusp alfa protein, human 1 bemcentinib 1 belinostat 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡